MyMedR

Displaying all 5 publications

Abstract:

Sort:

Fulltext On Scalability of FDD-Based Cell-Free Massive MIMO Framework

Hassan B, Baig S, Aslam S

Sensors (Basel), 2023 Aug 07;23(15).
PMID: 37571774 DOI: 10.3390/s23156991

Cell-free massive multiple-input multiple-output (MIMO) systems have the potential of providing joint services, including joint initial access, efficient clustering of access points (APs), and pilot allocation to user equipment (UEs) over large coverage areas with reduced interference. In cell-free massive MIMO, a large coverage area corresponds to the provision and maintenance of the scalable quality of service requirements for an infinitely large number of UEs. The research in cell-free massive MIMO is mostly focused on time division duplex mode due to the availability of channel reciprocity which aids in avoiding feedback overhead. However, the frequency division duplex (FDD) protocol still dominates the current wireless standards, and the provision of angle reciprocity aids in reducing this overhead. The challenge of providing a scalable cell-free massive MIMO system in an FDD setting is also prevalent, since computational complexity regarding signal processing tasks, such as channel estimation, precoding/combining, and power allocation, becomes prohibitively high with an increase in the number of UEs. In this work, we consider an FDD-based scalable cell-free network with angular reciprocity and a dynamic cooperation clustering approach. We have proposed scalability for our FDD cell-free and performed a comparative analysis with reference to channel estimation, power allocation, and precoding/combining techniques. We present expressions for scalable spectral efficiency, angle-based precoding/combining schemes and provide a comparison of overhead between conventional and scalable angle-based estimation as well as combining schemes. Simulations confirm that the proposed scalable cell-free network based on an FDD scheme outperforms the conventional matched filtering scheme based on scalable precoding/combining schemes. The angle-based LP-MMSE in the FDD cell-free network provides 14.3% improvement in spectral efficiency and 11.11% improvement in energy efficiency compared to the scalable MF scheme.
Fulltext Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?

Baig S, Seevasant I, Mohamad J, Mukheem A, Huri HZ, Kamarul T

Cell Death Dis, 2016;7:e2058.
PMID: 26775709 DOI: 10.1038/cddis.2015.275

Underneath the intricacy of every cancer lies mysterious events that impel the tumour cell and its posterity into abnormal growth and tissue invasion. Oncogenic mutations disturb the regulatory circuits responsible for the governance of versatile cellular functions, permitting tumour cells to endure deregulated proliferation, resist to proapoptotic insults, invade and erode normal tissues and above all escape apoptosis. This disruption of apoptosis has been highly implicated in various malignancies and has been exploited as an anticancer strategy. Owing to the fact that apoptosis causes minimal inflammation and damage to the tissue, apoptotic cell death-based therapy has been the centre of attraction for the development of anticancer drugs. Increased understanding of the molecular pathways underlying apoptosis has enabled scientists to establish unique approaches targeting apoptosis pathways in cancer therapeutics. In this review, we reconnoitre the two major pathways (intrinsic and extrinsic) targeted cancer therapeutics, steering toward chief modulators of these pathways, such as B-cell lymphoma 2 protein family members (pro- and antiapoptotic), inhibitor of apoptosis proteins, and the foremost thespian of extrinsic pathway regulator, tumour necrosis factor-related apoptosis-inducing agent. Together, we also will have a look from clinical perspective to address the agents (drugs) and therapeutic strategies adopted to target these specific proteins/pathways that have entered clinical trials.
Effect of Chitosan Nanoparticle-Loaded Thymus serpyllum on Hydrogen Peroxide-Induced Bone Marrow Stromal Cell Damage

Baig S, Azizan AHS, Raghavendran HRB, Natarajan E, Naveen S, Murali MR, et al.

Stem Cells Int, 2019;2019:5142518.
PMID: 30956670 DOI: 10.1155/2019/5142518

We have determined the protective effects of Thymus serpyllum (TS) extract and nanoparticle-loaded TS on hydrogen peroxide-induced cell death of mesenchymal stromal cells (MSCs) in vitro. Gas chromatography-mass spectroscopy confirmed the spectrum of active components in the extract. Out of the three different extracts, the hexane extract showed significant free radical scavenging activity. Treatment of MSCs with H2O2 (hydrogen peroxide) significantly increased intracellular cell death; however, pretreatment with TS extract and nanoparticle-loaded TS (200 μg/ml) suppressed H2O2-induced elevation of Cyt-c and MMP13 and increased the survival rates of MSCs. H2O2-induced (0.1 mM) changes in cytokines were attenuated in the extract and nanoparticles by pretreatment and cotreatment at two time points (p < 0.05). H2O2 increased cell apoptosis. In contrast, treatment with nanoparticle-loaded TS suppressed the percentage of apoptosis considerably (p < 0.05). Therefore, TS may be considered as a potential candidate for enhancing the effectiveness of MSC transplantation in cell therapy.
An international Delphi consensus on patient preparation for metabolic and bariatric surgery

Clyde DR, Adib R, Baig S, Bhasker AG, Byrne J, Cameron D, et al.

Clin Obes, 2024 Dec 14.
PMID: 39673462 DOI: 10.1111/cob.12722

Global obesity rates have risen dramatically, now exceeding deaths from starvation. Metabolic and bariatric surgery (MBS), initially for severe obesity (BMI ≥35 kg/m2), is performed globally over 500 000 times annually, offering significant metabolic benefits beyond weight loss. However, varying eligibility criteria globally impact patient care and healthcare resources. Updated in 2022, ASMBS and IFSO guidelines aim to standardise MBS indications, reflecting current understanding and emphasising comprehensive preoperative assessments. Yet, clinical variability persists, necessitating consensus-based recommendations. This modified Delphi study engaged 45 global experts to establish consensus on perioperative management in MBS. Experts selected from bariatric societies possessed expertise in MBS and participated in a two-round Delphi protocol. Consensus was achieved on 90 of 169 statements (53.3%), encompassing multidisciplinary team composition, patient selection criteria, preoperative testing, and referral pathways. The agreement highlighted the critical role of comprehensive preoperative assessments and the integration of healthcare professionals in MBS. These findings offer essential insights to standardise perioperative practices and advocate for evidence-based guidelines in MBS globally. The study underscores the need for unified protocols to optimise outcomes and guide future research in MBS.
30-day morbidity and mortality of revisional bariatric surgery - An international multi-centre collaborative (BROAD) study

Nasta AM, Goel R, Singhal R, Lemmens L, Baig S, Seki Y, et al.

Obes Res Clin Pract, 2024;18(3):195-200.
PMID: 38955573 DOI: 10.1016/j.orcp.2024.06.001

INTRODUCTION: Revisional bariatric surgery (RBS) for insufficient weight loss/weight regain or metabolic relapse is increasing worldwide. There is currently no large multinational, prospective data on 30-day morbidity and mortality of RBS. In this study, we aimed to evaluate the 30-day morbidity and mortality of RBS at participating centres.
METHODS: An international steering group was formed to oversee the study. The steering group members invited bariatric surgeons worldwide to participate in this study. Ethical approval was obtained at the lead centre. Data were collected prospectively on all consecutive RBS patients operated between 15th May 2021 to 31st December 2021. Revisions for complications were excluded.
RESULTS: A total of 65 global centres submitted data on 750 patients. Sleeve gastrectomy (n = 369, 49.2 %) was the most common primary surgery for which revision was performed. Revisional procedures performed included Roux-en-Y gastric bypass (RYGB) in 41.1 % (n = 308) patients, One anastomosis gastric bypass (OAGB) in 19.3 % (n = 145), Sleeve Gastrectomy (SG) in 16.7 % (n = 125) and other procedures in 22.9 % (n = 172) patients. Indications for revision included weight regain in 615(81.8 %) patients, inadequate weight loss in 127(16.9 %), inadequate diabetes control in 47(6.3 %) and diabetes relapse in 27(3.6 %). 30-day complications were seen in 80(10.7 %) patients. Forty-nine (6.5 %) complications were Clavien Dindo grade 3 or higher. Two patients (0.3 %) died within 30 days of RBS.
CONCLUSION: RBS for insufficient weight loss/weight regain or metabolic relapse is associated with 10.7 % morbidity and 0.3 % mortality. Sleeve gastrectomy is the most common primary procedure to undergo revisional bariatric surgery, while Roux-en-Y gastric bypass is the most commonly performed revision.